ABB  Vol.1 No.3 , August 2010
Intra-renal and urinary RNA expression of podcyte-associated molecules in patients with IgA nephropathy
ABSTRACT
Background Podocyte injury probably plays important roles in the pathogenesis of IgA nephropathy (IgAN). We studied intra-renal and urinary messenger RNA (mRNA) expression of podocyte-associated molecules in patients with IgAN. Methods We studied 43 consecutive patients with biopsy-proven IgAN. Intra-renal and urinary expression of mRNAs was determined and compared to that of 20 patients with nephrectomy for kidney cancer and 12 normal subjects. Results Intra-renal mRNA expression levels of nephrin, podocin and synaptopodin were significantly lower in patients with IgAN than that of controls. In contrast, their urinary mRNA expression levels were similar. Intra-renal gene expression of nephrin inversely correlated with proteinuria (r = –0.620, P < 0.001), GFR (r = 0.538, P < 0.001), and the degree of tubulointerstitial scarring (r = –0.423, P = 0.013). After followed for an average of 33.4 ? 12.6 months, intra-renal nephrin expression significantly correlated with the rate of GFR decline (r = 0.324, P = 0.041). Conclusions Intra-renal mRNA expression of podocyte associated molecules was down-regulated in patients with IgAN, and the degree of down- regulation of nephrin correlated with disease severity and the rate of progression. Our result supports the hypothesis that podocyte injury is an important component in the pathophysiology of IgAN.

Cite this paper
nullWang, G. , Kwan, B. , Lai, F. , Choi, P. , Chow, K. , Li, P. and Szeto, C. (2010) Intra-renal and urinary RNA expression of podcyte-associated molecules in patients with IgA nephropathy. Advances in Bioscience and Biotechnology, 1, 232-237. doi: 10.4236/abb.2010.13032.
References
[1]   Donadio, J.V. and Grande, J.P. (2002) IgA nephropathy. New England Journal of Medicine, 347(10), 738-748.

[2]   Berthoux, F.C., Mohey, H. and Afiani, A. (2008) Natural history of primary IgA nephropathy. Seminars in Nephrology, 28(1), 4-9.

[3]   Tan, C.H., Loh, P.T., Yang, W.S., Chan, C.M. (2008) Mycophenolate mofetil in the treatment of IgA nephropathy: A systematic review. Singapore Medical Journal, 49(10), 780-785.

[4]   Lemley, K.V., Lafayette, R.A., Safai, M., Derby, G., Blouch, K., Squarer, A. and Myers, B.D. (2002) Podocytopenia and disease severity in IgA nephropathy. Kidney International, 61(4), 1475-1485.

[5]   Hishiki, T., Shirato, I., Takahashi, Y., Funabiki, K., Horikoshi, S., Tomino, Y. (2001) Podocyte injury predicts prognosis in patients with IgA nephropathy using a small amount of renal biopsy tissue. Kidney and Blood Pressure Research, 24(2), 99-104.

[6]   Qiu, L.Q., Sinniah, R., IHH, S. (2004) Downregulation of Bcl-2 by podocytes is associated with progressive glomerular injury and clinical indices of poor renal prognosis in human IgA nephropathy. Journal of the American Society of Nephrology, 15(1), 79-90.

[7]   Lai, K.N., Leung, J.C., Chan, L.Y., Saleem, M.A., Mathieson, P.W., Tam, K.Y., Xiao, J., Lai, F.M. and Tang, S.C. (2009) Podocyte injury induced by mesangial-derived cytokines in IgA nephropathy. Nephrology Dialysis Transplantation, 24(1), 62-72.

[8]   Levey, A.S., Bosch, J.P., Lewis, J.B., Greene, T., Rogers, N. and Roth, D. (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Annals of Internal Medicine, 130(6), 461-470.

[9]   Mitch, W. (1986) Measuring the rate of progression of renal insufficiency. In: Mitch, W., Stein, J. and Brenner, B., Eds., The Progressive Nature of Renal Disease, Churchill Livingstone Inc, New York, 203-220.

[10]   Bhandari, S., Watson, N., Long, E., Sharpe, S., Zhong, W., Xu, S.Z. and Atkin, S.L. (2008) Expression of somatostatin and somatostatin receptor subtypes 1-5 in human normal and diseased kidney. Journal of Histochemistry & Cytochemistry, 56(8), 733-743.

[11]   Wang, C., Peng, H., Tang, H., Liu, X., Chen, Z., Lou, T. and Yu, X. (2007) Serum IgA1 from IgA nephropathy patients induces apoptosis in podocytes through direct and indirect pathways. Clinical and Investigative Medicine, 30(6), E240-249.

[12]   Hara, M., Yanagihara, T. and Kihara, I. (2007) Cumulative excretion of urinary podocytes reflects disease progression in IgA nephropathy and Schonlein-Henoch purpura nephritis. Clinical Journal of the American Society of Nephrology, 2(2), 231-238.

[13]   Ng, W.L., Chan, K.W., Yeung, C.K. and Kwan, S. (1984) Peripheral glomerular capillary wall lesions in IgA nephropathy and their implications. Pathology, 16(3), 324- 330.

[14]   Gagliardini, E., Benigni, A., Tomasoni, S., Abbate, M., Kalluri, R. and Remuzzi, G. (2003) Targeted downregulation of extracellular nephrin in human IgA nephropathy. American Journal of Nephrology, 23(4), 277-286.

[15]   Doublier, S., Ruotsalainen, V., Salvidio, G., Lupia, E., Biancone, L., Conaldi, P.G., Reponen, P., Tryggvason, K. and Camussi, G. (2001) Nephrin redistribution on podocytes is a potential mechanism for proteinuria in patients with primary acquired nephrotic syndrome. American Journal of Pathology, 158(5), 1723-1731.

[16]   Wang, G., Lai, F.M., Lai, K.B., Chow, K.M., Li, K.T. and Szeto, C.C. (2007) Messenger RNA expression of podocyte-associated molecules in the urinary sediment of patients with diabetic nephropathy. Nephron Clinical Practice, 106(4), c169-179.

[17]   Wang, G., Lai, F.M., Kwan, B.C., Lai, K.B., Chow, K.M., Li, P.K. and Szeto, C.C. (2009) Podocyte loss in human hypertensive nephrosclerosis. American Journal of Hypertension, 22(3), 300-306.

[18]   Vogelmann, S.U., Nelson, W.J., Myers, B.D. and Lemley, K.V. (2003) Urinary excretion of viable podocytes in health and renal disease. American Journal of Physiology Renal Physiology, 285(1), F40-48.

[19]   Ruotsalainen, V., Ljungberg, P., Wartiovaara, J., Lenkkeri, U., Kestila, M., Jalanko, H., Holmberg, C. and Tryg- gvason, K. (1999) Nephrin is specifically located at the slit diaphragm of glomerular podocytes. Proceedings of the National Academy of Sciences, USA, 96(14), 7962- 7967.

[20]   Jalanko, H. (2003) Pathogenesis of proteinuria: Lessons learned from nephrin and podocin. Pediatric Nephrology, 18(6), 487-491.

 
 
Top